Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 7 ... pointed out an interesting aspect of the linking between FVL gene variant, diabetes and atherothrombosis and other vascular complications, although data on larger population are needed; this ...
2009 OCT 5 ... I has been found in atherosclerotic plaques, its potential role in the pathogenesis of atherothrombosis remains elusive," scientists in Changsha, People's Republic of China report. ...
2009 NOV 1 ... agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. The compound is an orally administered himbacine analog that potently antagonizes the ...
2009 NOV 30 ... risk of venous thrombosis, it remains uncertain whether low protein C increases risk of atherothrombosis." "To examine whether low protein C may be a risk factor for ischemic ...
2009 SEP 14 ... This duality of the metabolism of arachidonic acid has dominated our thinking about atherothrombosis for decades, and rightfully still does. As scientific understanding progressed, it ...
2009 OCT 5 ... of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosis. Thrombosis and Haemostasis, 2009;102(2):248-257). For additional ...
2009 AUG 17 ... inflammation-sensitive biomarkers with a proven prognostic value in the field of atherothrombosis. However, the WBCC count range and determinants have not been explored in the absence of ...
2009 AUG 17 ... A report, 'Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT),' is ...
2009 NOV 30 ... represents a potential future therapeutic target for the prevention and treatment of atherothrombosis." "To investigate the effects of the novel small molecule P-selectin ...
2009 NOV 2 ... Activation of coagulation leads to the late complication of atherosclerosis, namely atherothrombosis with its clinical manifestations stroke, unstable angina, myocardial infarction, and ...
2009 NOV 1 ... lesions. Expression of heregulin-beta(1) was observed at trace levels in intracoronary atherothrombosis obtained by aspiration thrombectomy from acute coronary syndrome patients. ...
2009 OCT 19 ... results, 'Three-year follow-up and event rates in the international REduction of Atherothrombosis for Continued Health Registry,' are detailed in a study published in European Heart ...
2009 AUG 17 ... A report, 'The translational therapeutics of prostaglandin inhibition in atherothrombosis,' is newly published data in Journal of Thrombosis and Haemostasis. "Prostaglandins, ...
2009 OCT 5 ... peripheral vascular diseases. Antiplatelet agents (APA), key tools in the treatment of atherothrombosis, therefore became a mainstay medication for a wide range of vascular diseases," ...
2009 SEP 21 ... cardiovascular risk associated with a diagnosis of PAD. For example, in the Reduction of Atherothrombosis for Continued Health (REACH) Registry, patients with PAD experienced the highest rates ...
2009 AUG 31 ... Journal of Thrombosis and Haemostasis (Platelet hyperreactivity, scavenger receptors and atherothrombosis. Journal of Thrombosis and Haemostasis, 2009;7(Suppl. 1):218-221). For ...
2009 SEP 14 ... had the lowest. The results from the international REACH (Reduction of Atherothrombosis for Continued Health) Registry, presented by a researcher from Northwestern University ...
